Regulating AI Companions

2026-07-11 · Source: The Regulatory Review · Field: Legal & Regulatory — Compliance & Risk Management, Regulatory Affairs & Government Relations, Specialized Legal Practice Areas · Depth: Advanced, short

Summary

Scholars are examining the regulatory challenges posed by AI companions, which are widely used, with nearly three in four U.S. teenagers having used one and half using them regularly. These tools simulate friendship, romance, therapy, and education, offering benefits like reduced loneliness and accessible mental health support. However, they also present significant risks including emotional dependency, manipulation, privacy loss, child safety harms, and unsafe mental health advice. Legal scholars debate whether to classify AI companions as consumer products, medical tools, or relationship-like technologies. Specific proposals include FDA regulation for therapy chatbots, applying a products liability framework to AI software, drawing on family law principles for relationship-forming AI, and professionalizing AI engineering with licensing and ethical standards to ensure accountability and user safety.

Key takeaway

For legal professionals and policymakers developing AI governance, you must consider the multifaceted nature of AI companions, which blur lines between products, medical tools, and relationships. Your regulatory approach should integrate health law, products liability, and family law principles to address risks like emotional dependency, data privacy, and unsafe advice. Prioritize establishing clear liability, mandating transparency, and exploring professionalization for AI engineers to ensure user safety and responsible development.

Key insights

AI companions require diverse legal frameworks to mitigate risks like dependency and privacy loss while preserving benefits.

Principles

• AI companions foster user attachments, creating vulnerabilities.
• Regulation must build in accountability, transparency, and democratic values.
• Existing legal frameworks often fall short for AI agents.

Method

Regulate AI therapy chatbots as medical devices under FDA standards. Apply products liability to AI software for design-defect and failure-to-warn claims. Professionalize AI engineering through licensing and ethical standards.

In practice

• Implement clear labeling and data security protections for chatbots.
• Develop mechanisms for allocating responsibility among AI developers and users.
• Establish professional discipline and malpractice accountability for AI engineers.

Topics

• AI Regulation
• AI Companions
• Products Liability
• Health Law
• Data Privacy
• AI Ethics
• AI Governance

Best for: CTO, VP of Engineering/Data, Director of AI/ML, Legal Professional, Policy Maker, AI Ethicist

Related on AIssential

• China’s AI companion rules: what Beijing is really going after — AI companions are conversational agents built for sustained personal relationships, prompting regulatory scrutiny like China's rules.
• Regulate Companies, Not Children — Social media and AI platforms face increasing legal accountability for harms to children due to addictive designs and inadequate safeguards.
• Debevoise Contributes to the Chambers Artificial Intelligence Global Practice Guide 2026 — The legal and regulatory landscape for AI is rapidly evolving, demanding comprehensive guidance for organizations.
• The conceptualization of artificial intelligence as a neutral tool is increasingly untenable in light of its emergent properties and autonomous behavior. — Agentic AI's autonomous behavior necessitates strict liability and robust regulation to prevent severe psychological, physical, and professional harms.
• Onward, Friends — Protecting digital civil liberties requires continuous advocacy against evolving surveillance and the systemic challenges posed by AI.
• My year with the robots: how Joanna Stern let AI into her home, work – and heart — Deep AI integration, especially with companion chatbots, can create unexpected emotional connections that blur human-machine boundaries.

See Counsel's argued verdicts on the open AI decisions leaders are weighing →

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by The Regulatory Review.